| 标题 |
Five-year outcomes of pembrolizumab versus chemotherapy in Chinese patients with non-small-cell lung cancer and programmed cell death ligand 1 tumor proportion score ≥1%: KEYNOTE-042 China study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Int J Cancer 作者:Wu YL, Zhang L, Fan Y, Zhou J, Zhang L, Zhou Q, Li W, Hu C, Chen G, Zhang X, Zhou C, Arenas CG, Chen Z, Yu WC, Mok TSK 出版日期:2025-12-31 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)